These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24231739)
1. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease. Korutla L; Furlong HA; Mackler SA Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739 [TBL] [Abstract][Full Text] [Related]
2. Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis. Scofield MD; Korutla L; Jackson TG; Kalivas PW; Mackler SA Neuroscience; 2012 Dec; 227():44-54. PubMed ID: 23022214 [TBL] [Abstract][Full Text] [Related]
3. NAC1, a cocaine-regulated POZ/BTB protein interacts with CoREST. Korutla L; Degnan R; Wang P; Mackler SA J Neurochem; 2007 May; 101(3):611-8. PubMed ID: 17254023 [TBL] [Abstract][Full Text] [Related]
4. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease. Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin. Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272 [TBL] [Abstract][Full Text] [Related]
6. NAC1, a POZ/BTB protein that functions as a corepressor. Korutla L; Wang P; Jackson TG; Mackler SA Neurochem Int; 2009; 54(3-4):245-52. PubMed ID: 19121354 [TBL] [Abstract][Full Text] [Related]
7. CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism. Kumar P; Ambasta RK; Veereshwarayya V; Rosen KM; Kosik KS; Band H; Mestril R; Patterson C; Querfurth HW Hum Mol Genet; 2007 Apr; 16(7):848-64. PubMed ID: 17317785 [TBL] [Abstract][Full Text] [Related]
8. The ubiquitin E3 ligase Parkin regulates neuronal Ca Grimaldo L; Sandoval A; Duran P; Gómez Flores-Ramos L; Felix R J Neurophysiol; 2022 Dec; 128(6):1555-1564. PubMed ID: 36350063 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells. Kyratzi E; Pavlaki M; Kontostavlaki D; Rideout HJ; Stefanis L J Neurochem; 2007 Aug; 102(4):1292-303. PubMed ID: 17472700 [TBL] [Abstract][Full Text] [Related]
10. The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures. Korutla L; Wang PJ; Mackler SA J Neurochem; 2005 Aug; 94(3):786-93. PubMed ID: 16033423 [TBL] [Abstract][Full Text] [Related]
11. NAC1 regulates the recruitment of the proteasome complex into dendritic spines. Shen H; Korutla L; Champtiaux N; Toda S; LaLumiere R; Vallone J; Klugmann M; Blendy JA; Mackler SA; Kalivas PW J Neurosci; 2007 Aug; 27(33):8903-13. PubMed ID: 17699672 [TBL] [Abstract][Full Text] [Related]
12. Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. Roth JA; Singleton S; Feng J; Garrick M; Paradkar PN J Neurochem; 2010 Apr; 113(2):454-64. PubMed ID: 20089134 [TBL] [Abstract][Full Text] [Related]
14. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease]. Hattori N Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506 [TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells. Biasini E; Fioriti L; Ceglia I; Invernizzi R; Bertoli A; Chiesa R; Forloni G J Neurochem; 2004 Feb; 88(3):545-53. PubMed ID: 14720204 [TBL] [Abstract][Full Text] [Related]
16. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease. Song P; Li S; Wu H; Gao R; Rao G; Wang D; Chen Z; Ma B; Wang H; Sui N; Deng H; Zhang Z; Tang T; Tan Z; Han Z; Lu T; Zhu Y; Chen Q Protein Cell; 2016 Feb; 7(2):114-29. PubMed ID: 26746706 [TBL] [Abstract][Full Text] [Related]
17. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618 [TBL] [Abstract][Full Text] [Related]
18. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300 [TBL] [Abstract][Full Text] [Related]
19. Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function. Rosen KM; Moussa CE; Lee HK; Kumar P; Kitada T; Qin G; Fu Q; Querfurth HW J Neurosci Res; 2010 Jan; 88(1):167-78. PubMed ID: 19610108 [TBL] [Abstract][Full Text] [Related]